Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you consider consolidative RT in patients with metastatic bladder cancer after near complete response after Keytruda?
Answer from: Radiation Oncologist at Community Practice
Generally, no I wouldn't, as I can't quantify the risk-to-benefit ratio given the paucity of data.
Sign In
or
Register
to read more
20304
Related Questions
How would you treat an isolated urothelial cancer local recurrence abutting the duodenum?
What are your institution's standard liquid intake instructions for prostate cancer patients going through definitive external beam radiation?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
Are there any scenarios in which you would offer SBRT as your preferred treatment approach for appropriate candidates with intermediate risk prostate cancer?
What is the rationale for the recent change in the NCCN criteria for very high risk prostate cancer?
What are your top takeaways in GU Cancers from ASCO 2025?
How do you manage prostate cancer in patients that cannot swallow pills?
In light of the recent data indicating increased late grade 3 to 5 toxicities (LTOX3) after hypofractionated salvage radiation therapy, will you continue to offer these regimes to patients?
What is your preferred approach in a patient unable to fill their bladder during prostate radiotherapy?
What SBRT dose would you give to a single external iliac lymph node recurrence (1 cm size) for a patient previously treated with salvage radiation to the pelvis?